Fatty acid amide hydrolase inhibitors and the marijuana debate [2]

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Access to Document

@article{181dbac2b5cb48a699b85f613b3f01f8,

title = "Fatty acid amide hydrolase inhibitors and the marijuana debate [2]",

author = "David Gurwitz and Abraham Weizman",

year = "2001",

month = nov,

day = "3",

doi = "10.1016/S0140-6736(01)06597-7",

language = "אנגלית",

volume = "358",

pages = "1548",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Ltd.",

number = "9292",

}

TY - JOUR

T1 - Fatty acid amide hydrolase inhibitors and the marijuana debate [2]

AU - Gurwitz, David

AU - Weizman, Abraham

PY - 2001/11/3

Y1 - 2001/11/3

UR - http://www.scopus.com/inward/record.url?scp=0035802682&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(01)06597-7

DO - 10.1016/S0140-6736(01)06597-7

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

AN - SCOPUS:0035802682

SN - 0140-6736

VL - 358

SP - 1548

JO - The Lancet

JF - The Lancet

IS - 9292

ER -